Skip to Main Content

Paper Details

A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis.
Aliment Pharmacol Ther
1
2023
Author NameAffiliation
William J SandbornUniversity of California
  • 1 - 1

Datasets

Release 1.2